ESR1 and breast cancer: Similarly, in estrogen receptor-positive (ESR+) human breast cancer cells lines (T47D, BT474 and MCF7), ANKLE2 overexpression contributes to tamoxifen resistance and accelerated tumor growth (Gao et al., 2018).